Tag Archive | Gilead

US: Patient organisations prefer generic HIV prevention pill

US: Patient organisations prefer generic HIV prevention pill

(Reuters) – Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source – patient advocates. Such groups have traditionally lobbied for insurance coverage of newer HIV drugs, regardless of expense. But at least three […]